varieti
respiratori
complic
encount
pregnanc
understand
pathophysiolog
pregnanc
import
manag
complic
despit
chang
immun
incid
respiratori
infect
higher
pregnanc
asthma
common
preexist
medic
disord
encount
pregnanc
preval
women
childbear
age
increas
slight
increas
risk
pregnanc
suboptim
therapi
common
reason
poor
control
xray
obtain
whenev
clinic
indic
drug
use
manag
asthma
long
track
record
safeti
women
poor
control
pregnanc
good
liaison
respiratori
physician
obstetrician
tuberculosi
increasingli
import
may
complic
human
immunodefici
viru
infect
firstlin
antitubercul
drug
safe
administ
pregnanc
lactat
normal
pregnanc
associ
increas
ventil
mainli
due
deeper
frequent
breath
chang
lead
increas
basal
oxygen
consumpt
major
women
awar
breath
may
lead
common
complaint
short
breath
common
third
trimest
may
lead
diagnost
confus
late
pregnanc
diaphragmat
elev
caus
enlarg
uteru
lead
decreas
function
residu
capac
frc
diaphragm
excurs
unaffect
vital
capac
unchang
pregnancyinduc
physiolog
chang
occur
respiratori
system
summar
tabl
asthma
common
preexist
medic
disord
encount
pregnanc
preval
women
childbear
age
increas
biggest
danger
mother
fetu
come
poorli
control
undertr
diseas
manag
pregnanc
includ
educ
regard
inhal
use
reassur
safeti
medic
use
control
asthma
natur
histori
asthma
pregnanc
variabl
literatur
address
effect
pregnanc
asthma
conflict
consist
trend
improv
worsen
diseas
sever
north
american
studi
suggest
one
five
one
nine
women
asthma
least
one
admiss
emerg
depart
requir
hospit
cours
asthma
pregnanc
individu
woman
larg
unpredict
women
commenc
pregnanc
sever
poorli
control
diseas
experi
worsen
symptom
particularli
third
trimest
compar
mild
diseas
evid
cours
diseas
similar
success
pregnanc
mani
asthmat
experi
worsen
symptom
pregnanc
stop
reduc
medic
due
fear
either
medic
advis
safeti
current
uk
guidelin
recommend
prepregn
counsel
women
asthma
regard
import
safeti
continu
asthma
medic
pregnanc
ensur
good
control
effect
asthma
pregnanc
pregnanc
increas
incid
complic
matern
fetal
complic
often
seriou
happen
nearli
exclus
patient
sever
andor
poorli
control
asthma
recent
studi
common
matern
complic
meconiumstain
amniot
fluid
preterm
labour
deliveri
oligohydramnio
pregnancyinduc
hypertens
evid
modest
associ
matern
asthma
risk
preterm
prematur
ruptur
membran
common
neonat
complic
meconium
stain
preterm
infant
intrauterin
growth
restrict
iugr
women
requir
system
steroid
like
oligohydramnio
iugr
meconium
stain
pregnancyinduc
hypertens
pregnanc
seen
opportun
optim
asthma
control
prevent
acut
deterior
success
manag
asthma
pregnanc
requir
cooper
multidisciplinari
approach
obstetrician
midwiv
physician
nurs
specialist
manag
asthma
woman
includ
object
assess
pulmonari
function
fetal
well
home
peak
flow
monitor
person
selfmanag
plan
success
wellmotiv
pregnant
asthmat
avoid
asthma
trigger
pharmacolog
therapi
patient
educ
drug
treatment
asthma
pregnanc
similar
treatment
nonpregn
women
drug
commonli
use
treat
asthma
includ
shortand
longact
agonist
inhal
corticosteroid
methyl
xanthin
safe
pregnanc
fluticason
may
use
requir
high
dose
inhal
steroid
system
corticosteroid
seriou
wellknown
sideeffect
given
frequent
high
dose
prolong
period
women
doctor
reluct
use
steroid
pregnanc
concern
misplac
steroid
use
treat
asthma
pregnanc
way
reason
nonpregn
state
prednisolon
metabol
placenta
therefor
small
quantiti
activ
drug
reach
fetu
sever
studi
suggest
increas
risk
abort
stillbirth
congenit
malform
advers
fetal
effect
neonat
death
attribut
treat
mother
steroid
matern
advers
effect
steroid
therapi
pregnanc
includ
increas
risk
infect
reduc
glucos
toler
increas
gestat
diabet
develop
hyperglycaemia
treatabl
insulin
indic
discontinu
decreas
dose
oral
steroid
requir
must
determin
asthma
rare
import
psychiatr
sideeffect
oral
glucocorticoid
prednisolon
mg
rememb
women
commenc
steroid
review
within
week
data
regard
safeti
leukotrien
receptor
antagonist
pregnanc
extrem
limit
agent
commenc
pregnant
asthmat
may
howev
continu
women
achiev
asthma
control
achiev
medic
evid
pregnant
women
present
acut
asthmat
attack
less
like
nonpregn
counterpart
receiv
appropri
treatment
steroid
henc
like
experi
ongo
exacerb
last
two
confidenti
enquiri
matern
death
uk
eight
indirect
matern
death
asthma
drug
therapi
given
nonpregn
patient
asthma
includ
repeat
dose
inhal
agonist
earli
administr
oral
steroid
treatment
aim
maintain
partial
pressur
oxygen
greater
mmhg
oxygen
satur
sever
case
intraven
treatment
magnesium
sulphat
agonist
aminophyllin
use
indic
continu
fetal
assess
perform
asthma
uncontrol
sever
initi
assess
nonreassur
acut
sever
asthma
pregnanc
consid
emerg
treat
vigor
hospit
provid
abdomin
shield
use
chest
xray
result
minim
exposur
fetu
ioniz
radiat
clinic
indic
investig
must
never
withheld
patient
pregnant
women
poor
control
pregnanc
good
liaison
respiratori
physician
obstetrician
acut
attack
asthma
labour
deliveri
extrem
rare
women
reassur
accordingli
regularli
schedul
medic
continu
labour
oral
steroid
mg
prednisolon
week
preced
labour
receiv
parenter
steroid
hydrocortison
mg
hourli
labour
abl
restart
oral
medic
prostaglandin
use
induc
labour
bronchodil
safe
prostaglandin
indic
sever
postpartum
haemorrhag
use
extrem
caution
may
caus
bronchospasm
women
asthma
may
safe
use
form
pain
relief
labour
includ
epidur
analgesia
entonox
nonhistaminereleas
narcot
fentanyl
prefer
opiat
anaesthesia
requir
women
encourag
epidur
rather
gener
anaesthesia
increas
risk
sever
bronchospasm
chest
infect
associ
atelectasi
nonsteroid
antiinflammatori
drug
nsaid
commonli
use
pain
relief
follow
caesarean
section
women
asthma
ask
known
aspirin
nsaid
sensit
prior
use
drug
women
asthma
encourag
breastfe
risk
atop
diseas
develop
child
asthmat
woman
one
one
three
parent
atop
breastfeed
may
reduc
risk
inhal
prepar
oral
steroid
methylxanthin
safe
breastfeed
cystic
fibrosi
cf
autosomalrecess
disord
aris
defect
chromosom
region
code
cf
transmembran
regul
protein
abnorm
quantiti
function
protein
result
disturb
ion
water
transport
across
cell
mani
gland
respons
excess
thick
secret
caus
obstruct
organ
damag
loss
function
carrier
frequenc
caucasian
estim
preval
one
livebirth
clinic
pictur
domin
earli
persist
recurr
respiratori
infect
despit
attempt
prevent
aggress
treatment
howev
chronic
infect
progress
lung
damag
inevit
lead
respiratori
failur
featur
pancreat
insuffici
obstruct
necessit
lifelong
supplement
pancreat
enzym
malabsorpt
poor
growth
common
problem
includ
biliari
cirrhosi
obstruct
biliari
ductul
pancreat
endocrin
dysfunct
lead
glucos
intoler
cfrelat
diabet
osteoporosi
develop
special
centr
variou
intervent
median
surviv
steadili
increas
earli
teen
fourth
decad
beyond
present
feasibl
lung
transplant
help
improv
surviv
although
fertil
uniformli
affect
male
cf
suffer
rel
unaffect
femal
mani
hundr
cf
pregnanc
report
scandinavian
studi
report
pregnanc
women
cf
found
women
consid
pregnanc
could
achiev
although
assist
reproduct
requir
larg
proport
achiev
pregnanc
continu
choos
termin
pregnanc
option
indic
women
highli
motiv
healthi
women
cf
success
pregnanc
without
detriment
condit
hitherto
meant
women
without
pancreat
insuffici
howev
enzym
supplement
proper
diet
manag
increas
number
women
pancreat
insuffici
enter
pregnanc
rel
healthi
state
achiev
adequ
weight
gain
pregnanc
mani
requir
oral
nasogastr
gastrostomi
parenter
supplement
rate
preterm
birth
high
particularli
low
matern
weight
perinat
mortal
surprisingli
low
sometim
preterm
deliveri
may
medic
indic
unwel
women
therapeut
termin
pregnanc
may
requir
sick
women
underscor
need
effect
contracept
wish
get
pregnant
condit
complic
cfrelat
diabet
pregnanc
outcom
advers
affect
although
outcom
consist
improv
time
still
remain
inferior
compar
without
cfrelat
diabet
pregnanc
lung
transplant
recipi
cf
report
although
data
rel
limit
seem
agre
experi
organ
transplant
reject
transplant
common
first
year
pregnanc
ideal
embark
upon
time
pregnanc
undertaken
year
transplant
expect
associ
littl
risk
transplant
reject
organ
failur
fetal
anomali
sever
derang
liver
function
constitut
contraind
pregnanc
howev
mild
elev
liver
enzym
andor
abnorm
liver
ultrasound
scan
rel
common
major
impact
outcom
pulmonari
hypertens
right
heart
failur
contraind
pregnanc
women
cf
cf
autosom
transmit
diseas
genet
counsel
offer
women
cf
consid
pregnanc
partner
carrier
known
mutat
risk
cf
offspr
extrem
small
howev
babi
carrier
cf
gene
mutat
two
larg
studi
look
effect
pregnanc
cf
contradictori
north
american
studi
suggest
deleteri
effect
pregnanc
cf
worsen
lung
function
contrast
uk
studi
suggest
poor
lung
function
deliv
earlier
deliv
earlier
lost
pulmonari
function
compar
nonpregn
cf
control
match
sever
pregnanc
consid
state
rel
immunosuppress
studi
shown
matern
cellmedi
immun
depress
pregnanc
second
third
trimest
matern
lymphocyt
show
decreas
prolif
respons
solubl
antigen
allogen
lymphocyt
reduct
helper
cell
result
lower
helpersuppressor
ratio
caus
decreas
antibodi
product
polymorphonuclear
leukocyt
show
reduct
chemotact
respons
pregnanc
despit
immunosuppress
preval
pneumonia
pregnanc
differ
compar
nonpregn
individu
howev
complic
associ
pneumonia
may
common
common
caus
pneumonia
bacteri
viral
aspir
common
organ
caus
pneumonia
pregnanc
summar
tabl
similar
found
nonpregn
women
streptococcu
pneumonia
common
pathogen
identifi
pneumonia
mycoplasma
identifi
antepartum
pneumonia
mortal
mycoplasma
rare
recoveri
gener
occur
day
onset
symptom
although
legionella
encount
women
mortal
rate
high
type
influenza
frequent
caus
viral
pneumonia
associ
risk
pregnanc
nonpregn
state
varicella
pneumonia
may
occur
pregnant
women
varicella
infect
pneumonia
develop
day
vesicular
erupt
chest
xray
typic
show
diffus
nodular
pattern
varicella
pneumonia
suspect
pregnant
woman
prudent
admit
hospit
observ
treat
acyclovir
matern
infect
measl
rubeola
also
close
observ
develop
complic
includ
pneumonia
antibiot
treatment
recommend
event
superad
bacteri
infect
similar
nonpregn
state
pneumocysti
pcp
tuberculosi
frequent
pulmonari
complic
pregnant
women
infect
human
immunodefici
viru
hiv
pregnanc
appreci
alter
workup
manag
hivassoci
pneumonia
except
issu
relat
potenti
fetal
effect
pcp
aggress
cours
pregnanc
increas
morbid
mortal
matern
fetal
outcom
remain
dismal
treatment
sulphamethoxazoletrimethoprim
compar
therapi
may
result
improv
outcom
withhold
appropri
pcp
prophylaxi
may
advers
effect
matern
fetal
outcom
women
acquir
immunodefici
syndrom
aid
reproduct
age
pcp
common
caus
aidsrel
death
pregnant
women
usa
among
case
recent
review
divis
infecti
diseas
brooklyn
new
york
usa
mortal
rate
patient
higher
usual
report
hivinfect
individu
pcp
respiratori
failur
develop
patient
mechan
ventil
therefor
requir
surviv
rate
patient
requir
mechan
ventil
matern
fetal
outcom
better
case
pcp
third
trimest
pregnanc
coccidioidomycosi
carri
increas
risk
dissemin
higher
mortal
pregnanc
dissemin
occur
treatment
amphotericinb
indic
amphotericin
wide
use
without
evid
teratogen
use
fluconazol
firstlin
therapi
recommend
due
risk
fetal
malform
bacteri
pneumonia
frequent
hivposit
individu
seroneg
control
risk
highest
among
lymphocyt
count
among
injectiondrug
user
evid
chang
caus
organ
pneumonia
pregnanc
pseudomona
aeruginosa
becom
common
caus
commun
acquir
nosocomi
bacteri
pneumonia
hospit
patient
hiv
especi
low
leukocyt
lymphocyt
count
although
incid
nosocomi
bacteri
pneumonia
well
opportunist
infect
decreas
consider
advent
highli
activ
antiretrovir
therapi
still
repres
import
caus
mortal
global
hiv
epidem
increas
tuberculosi
allcaus
mortal
well
affect
individu
increas
caseload
due
hiv
may
also
contribut
increas
mortal
reduc
health
system
abil
provid
adequ
care
termin
pregnanc
usual
benefici
matern
outcom
unless
improv
respiratori
capac
may
improv
condit
addit
ethic
dilemma
termin
pregnanc
without
matern
consent
mother
unconsci
pregnant
women
increas
risk
aspir
due
increas
intraabdomin
tuberculosi
tb
becom
import
infect
particularli
increas
preval
hiv
seroposit
treatment
regimen
consist
initi
intens
phase
last
month
initi
phase
normal
consist
isoniazid
rifampicin
pyrazinamid
ethambutol
tubercl
bacilli
kill
rapidli
follow
continu
phase
usual
last
month
patient
neg
hiv
smearneg
pulmonari
extrapulmonari
tb
fulli
drug
suscept
littl
risk
select
resist
bacilli
lesion
gener
harbour
fewer
bacilli
howev
sinc
initi
resist
isoniazid
common
mani
area
hiv
test
tuberculosi
patient
practic
routin
recommend
ethambutol
includ
fourth
drug
initi
phase
treatment
patient
smearneg
pulmonari
extrapulmonari
tb
ethambutol
may
omit
patient
noncavitari
smearneg
pulmonari
tb
known
hivneg
patient
known
infect
fulli
drugsuscept
bacilli
young
children
primari
tb
breastfeed
safe
mother
receiv
antitubercul
therapi
sarcoidosi
multisystem
granulomat
diseas
unknown
aetiolog
sarcoidosi
complic
approxim
one
pregnanc
often
patient
asymptomat
chest
symptom
may
occur
erythema
nodosum
arthropathi
fever
hypercalcaemia
central
nervou
system
cn
involv
may
present
symptom
may
associ
abnorm
chest
xray
hilar
lymphadenopathi
erythema
nodosum
arthralgia
serum
angiotensinconvert
enzym
ace
level
use
outsid
pregnanc
monitor
diseas
activ
use
pregnanc
due
physiolog
increas
serum
ace
level
pregnanc
sarcoidosi
usual
selflimit
requir
therapi
risk
fetu
although
placent
sarcoid
granuloma
report
therapi
may
indic
event
cn
symptom
impair
respiratori
function
system
steroid
use
improv
diseas
patient
alreadi
steroid
continu
pregnanc
diseas
cours
often
unalt
sometim
improv
pregnanc
increas
steroid
dosag
deliveri
consid
postpartum
relaps
common
pregnant
women
sarcoidosi
avoid
vitamin
precipit
hypercalcaemia
sever
acut
respiratori
syndrom
sar
first
report
southeast
asia
caus
organ
new
coronaviru
induc
symptom
atyp
pneumonia
patient
rapidli
progress
toward
adult
respiratori
distress
syndrom
result
signific
hypoxia
infect
may
produc
uniqu
set
problem
encount
pregnanc
may
caus
miscarriag
earli
pregnanc
iugr
fetal
distress
intrauterin
death
matern
oxygen
satur
maintain
mother
nurs
upright
posit
women
ventil
best
nurs
left
later
posit
order
maxim
uteroplacent
blood
flow
cardiotocographi
ultrasound
assess
fetal
growth
doppler
assess
blood
flow
recommend
fetal
monitor
measur
sar
contagi
diseas
appropri
isol
infect
control
protocol
necessari
order
avoid
accident
infect
medic
staff
small
group
health
profession
alloc
look
infect
patient
period
monitor
sign
earli
infect
risk
infect
particularli
high
time
vagin
oper
deliveri
addit
precaut
neg
pressur
air
circul
recommend
broadspectrum
antibiot
clarithromycin
coamoxyclav
pregnanc
recommend
prevent
concomit
bacteri
infect
ribavarin
antivir
agent
tri
sar
clinic
deterior
howev
known
teratogen
anim
use
pregnanc
extrem
caution
termin
pregnanc
recommend
women
expos
agent
earli
pregnanc
high
dose
steroid
also
recommend
sick
patient
bacteri
infect
sideeffect
matern
steroid
therapi
known
guard
sar
viru
infect
may
particularli
sever
pregnanc
pregnanc
termin
option
earli
deliveri
reduc
oxygen
requir
may
vital
import
critic
ill
patient
rapid
deterior
multiorgan
failur
fetal
compromis
failur
maintain
matern
oxygen
even
ventil
support
along
obstetr
reason
constitut
indic
earli
deliveri
restrict
ventilatori
defect
character
reduct
lung
volum
associ
increas
forc
expiratori
volum
fvc
ratio
lung
expans
limit
due
alter
lung
parenchyma
abnorm
pleura
chest
wall
neuromuscular
apparatu
major
pulmonari
diseas
onset
childbear
year
chronic
respiratori
failur
due
restrict
lung
disord
appear
well
toler
pregnanc
provid
vital
capac
greater
l
secondari
pulmonari
hypertens
carbon
monoxid
odourless
tasteless
ga
high
affin
bind
haemoglobin
thu
displac
oxygen
imped
transfer
fetal
haemoglobin
higher
afin
carbon
monoxid
fetal
carboxyhaemoglobin
level
higher
mother
pregnant
women
fetus
toler
excess
carbon
monoxid
inhal
symptom
usual
appear
carboxyhaemoglobin
level
level
may
fatal
mother
presum
lower
level
fatal
fetu
treatment
support
administr
hyperbar
oxygen
practic
point
offer
prepregn
counsel
women
asthma
regard
import
safeti
continu
asthma
medic
pregnanc
ensur
good
asthma
control
monitor
pregnant
women
asthma
close
chang
cours
match
appropri
chang
treatment
acut
asthma
give
drug
therapi
nonpregn
patient
deliv
oxygen
immedi
maintain
satur
acut
asthma
pregnanc
treat
vigor
hospit
agonist
inhal
steroid
oral
intraven
theophyllin
use
normal
pregnanc
use
steroid
tablet
normal
indic
pregnanc
steroid
never
withheld
pregnanc
commenc
leukotrien
antagonist
pregnanc
may
continu
women
demonstr
signific
improv
asthma
control
agent
prior
pregnanc
achiev
medic
advis
women
acut
asthma
rare
labour
anaesthesia
requir
region
block
prefer
gener
anaesthesia
prostaglandin
safe
asthmat
prostaglandin
use
extrem
caution
risk
bronchospasm
encourag
women
breastfe
use
asthma
medic
normal
lactat
accord
recommend
manufactur
